Twenty Second Company

Twenty Second is a biotechnology company dedicated to advancing human health by modulating the endocannabinoid system (ECS). The company develops bio-identical cannabinoid formulations designed to address widespread conditions such as chronic pain, inflammation, and sleep disturbances. By leveraging a proprietary delivery platform, Twenty Second aims to provide high-bioavailability solutions that offer a safer alternative to traditional pharmaceuticals. Their approach combines rigorous scientific research with consumer-accessible health products to optimize the body's natural regulatory systems. The company's mission is to restore physiological balance and improve quality of life through precision cannabinoid science.